Monoclonal antibodies meeting the challenges in manufacturing, formulation, delivery and stability of final drug product
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Amsterdam
Woodhead Publishing is an imprint of Elsevier
[2015]
|
| Schriftenreihe: | Woodhead Publishing series in biomedicine
no. 77 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV043216348 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151216s2015 |||| o||u| ||||||eng d | ||
| 020 | |a 9780081002971 |9 978-0-08-100297-1 | ||
| 020 | |a 0081002971 |9 0-08-100297-1 | ||
| 020 | |a 9780081002964 |9 978-0-08-100296-4 | ||
| 035 | |a (OCoLC)908145774 | ||
| 035 | |a (DE-599)BVBBV043216348 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 616.07/98 | |
| 100 | 1 | |a Shire, Steven J. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Monoclonal antibodies |b meeting the challenges in manufacturing, formulation, delivery and stability of final drug product |c Steven J. Shire |
| 264 | 1 | |a Amsterdam |b Woodhead Publishing is an imprint of Elsevier |c [2015] | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Woodhead Publishing series in biomedicine |v no. 77 | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophy | ||
| 650 | 4 | |a Antibodies, Monoclonal / therapeutic use | |
| 650 | 4 | |a Technology, Pharmaceutical | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / General |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Clinical Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Diseases |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Evidence-Based Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Internal Medicine |2 bisacsh | |
| 650 | 4 | |a Monoclonal antibodies / Therapeutic use | |
| 650 | 4 | |a Monoclonal antibodies | |
| 650 | 4 | |a Evidenz-basierte Medizin | |
| 650 | 4 | |a Innere Medizin | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Monoclonal antibodies | |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780081002964 |x Verlag |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 940 | 1 | |q FLA_PDA_ESD | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028639372 | ||
Datensatz im Suchindex
| _version_ | 1804175721211363328 |
|---|---|
| any_adam_object | |
| author | Shire, Steven J. |
| author_facet | Shire, Steven J. |
| author_role | aut |
| author_sort | Shire, Steven J. |
| author_variant | s j s sj sjs |
| building | Verbundindex |
| bvnumber | BV043216348 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (OCoLC)908145774 (DE-599)BVBBV043216348 |
| dewey-full | 616.07/98 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.07/98 |
| dewey-search | 616.07/98 |
| dewey-sort | 3616.07 298 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02459nmm a2200517zcb4500</leader><controlfield tag="001">BV043216348</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151216s2015 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780081002971</subfield><subfield code="9">978-0-08-100297-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0081002971</subfield><subfield code="9">0-08-100297-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780081002964</subfield><subfield code="9">978-0-08-100296-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)908145774</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043216348</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.07/98</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Shire, Steven J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Monoclonal antibodies</subfield><subfield code="b">meeting the challenges in manufacturing, formulation, delivery and stability of final drug product</subfield><subfield code="c">Steven J. Shire</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam</subfield><subfield code="b">Woodhead Publishing is an imprint of Elsevier</subfield><subfield code="c">[2015]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Woodhead Publishing series in biomedicine</subfield><subfield code="v">no. 77</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibodies, Monoclonal / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Clinical Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Evidence-Based Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Internal Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Monoclonal antibodies / Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Monoclonal antibodies</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Evidenz-basierte Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Innere Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Monoclonal antibodies</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780081002964</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FLA_PDA_ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028639372</subfield></datafield></record></collection> |
| id | DE-604.BV043216348 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:20:47Z |
| institution | BVB |
| isbn | 9780081002971 0081002971 9780081002964 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028639372 |
| oclc_num | 908145774 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | 1 Online-Ressource |
| psigel | ZDB-33-ESD ZDB-33-EBS FLA_PDA_ESD |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | Woodhead Publishing is an imprint of Elsevier |
| record_format | marc |
| series2 | Woodhead Publishing series in biomedicine |
| spelling | Shire, Steven J. Verfasser aut Monoclonal antibodies meeting the challenges in manufacturing, formulation, delivery and stability of final drug product Steven J. Shire Amsterdam Woodhead Publishing is an imprint of Elsevier [2015] 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Woodhead Publishing series in biomedicine no. 77 Includes bibliographical references and index Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophy Antibodies, Monoclonal / therapeutic use Technology, Pharmaceutical HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Monoclonal antibodies / Therapeutic use Monoclonal antibodies Evidenz-basierte Medizin Innere Medizin Medizin http://www.sciencedirect.com/science/book/9780081002964 Verlag Volltext |
| spellingShingle | Shire, Steven J. Monoclonal antibodies meeting the challenges in manufacturing, formulation, delivery and stability of final drug product Antibodies, Monoclonal / therapeutic use Technology, Pharmaceutical HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Monoclonal antibodies / Therapeutic use Monoclonal antibodies Evidenz-basierte Medizin Innere Medizin Medizin |
| title | Monoclonal antibodies meeting the challenges in manufacturing, formulation, delivery and stability of final drug product |
| title_auth | Monoclonal antibodies meeting the challenges in manufacturing, formulation, delivery and stability of final drug product |
| title_exact_search | Monoclonal antibodies meeting the challenges in manufacturing, formulation, delivery and stability of final drug product |
| title_full | Monoclonal antibodies meeting the challenges in manufacturing, formulation, delivery and stability of final drug product Steven J. Shire |
| title_fullStr | Monoclonal antibodies meeting the challenges in manufacturing, formulation, delivery and stability of final drug product Steven J. Shire |
| title_full_unstemmed | Monoclonal antibodies meeting the challenges in manufacturing, formulation, delivery and stability of final drug product Steven J. Shire |
| title_short | Monoclonal antibodies |
| title_sort | monoclonal antibodies meeting the challenges in manufacturing formulation delivery and stability of final drug product |
| title_sub | meeting the challenges in manufacturing, formulation, delivery and stability of final drug product |
| topic | Antibodies, Monoclonal / therapeutic use Technology, Pharmaceutical HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Monoclonal antibodies / Therapeutic use Monoclonal antibodies Evidenz-basierte Medizin Innere Medizin Medizin |
| topic_facet | Antibodies, Monoclonal / therapeutic use Technology, Pharmaceutical HEALTH & FITNESS / Diseases / General MEDICAL / Clinical Medicine MEDICAL / Diseases MEDICAL / Evidence-Based Medicine MEDICAL / Internal Medicine Monoclonal antibodies / Therapeutic use Monoclonal antibodies Evidenz-basierte Medizin Innere Medizin Medizin |
| url | http://www.sciencedirect.com/science/book/9780081002964 |
| work_keys_str_mv | AT shirestevenj monoclonalantibodiesmeetingthechallengesinmanufacturingformulationdeliveryandstabilityoffinaldrugproduct |